The World Health Organization has endorsed an initiative to create a voluntary pool of intellectual property rights to tests, medicines and vaccines for COVID-19 so that products developed to tackle the coronavirus pandemic are shared equitably with all countries.
In addition, the board of the Medicines Patent Pool has said it would temporarily include medicines and diagnostics for COVID-19 in its licensing pool – and that the MPP was
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?